Atossa Genetics Receives Approval from the Swedish Medical Products Agency for Phase 2 Topical Endoxifen Study Nasdaq:ATOS

KeepHealthCare.ORG – Atossa Genetics Receives Approval from the Swedish Medical Products Agency for Phase 2 Topical Endoxifen Study Nasdaq:ATOS SEATTLE, April 30, 2018 (GLOBE NEWSWIRE) — Atossa Genetics Inc. (Nasdaq:ATOS) Continue reading

Myriad Receives Pre-Market Approval for its BRACAnalysis® Diagnostic System in Japan Nasdaq:MYGN

KeepHealthCare.ORG – Myriad Receives Pre-Market Approval for its BRACAnalysis® Diagnostic System in Japan Nasdaq:MYGN SALT LAKE CITY, April 02, 2018 (GLOBE NEWSWIRE) — Myriad Genetic Laboratories, Inc., a wholly-owned subsidiary Continue reading